CVS's already costly deal looks even more expensive after its warning on Thursday of a possible profit decline this year, despite an expected $1.2 billion benefit from tax cuts. CVS shares fell though it reported positive quarterly results.
It's hard to overshadow an industry-defining $67 billion merger of a drug-store mega-chain and large health insurer.